Aquatic Ecotoxicological Studies Market Size, Share & Trends Analysis Report By Type (Acute Toxicity Tests, Chronic Toxicity Tests, Bioaccumulation Studies, Biodegradation Studies), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Aquatic Ecotoxicological Studies Market Growth & Trends
The global aquatic ecotoxicological studies market size is expected t%li%reach USD 750.9 million by 2030 and grow at a CAGR of 7.2% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The market is driven by growing environmental awareness, the potential risk of toxic substances on aquatic organisms, and the increasing need for ecotoxicological studies t%li%identify and assess environmental risks and ensure compliance with environmental regulations.
Furthermore, increased focus on environmental sustainability and the requirement for regulatory practices t%li%characterize the long-term effects of toxic substances on aquatic ecosystems and pollution-related issues have fueled the market. Likewise, the studies provide crucial insights int%li%pollutant behavior, bioaccumulation, and ecological pathways, helping t%li%prevent environmental disasters and protect human health. Moreover, the companies are significantly focusing on developing formulations and solutions with lesser threats and adverse impacts on environmental entities. Hence, aquatic ecotoxicological studies are crucial t%li%evaluate the safety of these newly developed formulations on aquatic life before their widespread use.
In addition, the market is significantly growing, with players offering various testing services such as acute toxicity tests, chronic toxicity tests, bioaccumulation studies, biodegradation studies, and others, propelling the market growth. In addition, the growing expansion of facilities for aquatic ecotoxicological studies in various regions across the globe is gaining momentum, driven by a growing demand for environmentally friendly and sustainable options. For instance, in October 2022, Charles River Laboratories announced the ecotoxicology expansion of its 16,000 m2 site t%li%meet the growing demand for various time-critical testing programs. In addition, the company has completed the construction of six new ecotoxicology laboratories and has upgraded its existing facilities. At its Den Bosch site, the company will now offer expertise in ecotoxicology, toxicology, and environmental risk assessments. Additionally, new facilities will include a custom-designed fish culture system for aquatic ecotoxicology studies. Besides, in early 2023 the testing volumes performed are expected t%li%increase when changes t%li%endocrine disruptor testing requirements. This expansion will allow the company's clients t%li%effectively continue their studies in accordance with regulatory changes.
Some of the key players in the market are SGS SA, Charles River Laboratories Inc., Laboratory Corporation of America Holdings, Toxi-Coop Ltd., and others. Market players are adopting key strategic initiatives t%li%boost their market presence and expand their business. For instance, in October 2022, EcoAnalysts, Inc. announced its expansion in Florida after its acquisition of Hydrosphere Research Environmental Services, an aquatic ecotoxicity testing service provider.
Aquatic Ecotoxicological Studies Market Report Highlights
Aquatic Ecotoxicological Studies Market Growth & Trends
The global aquatic ecotoxicological studies market size is expected t%li%reach USD 750.9 million by 2030 and grow at a CAGR of 7.2% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The market is driven by growing environmental awareness, the potential risk of toxic substances on aquatic organisms, and the increasing need for ecotoxicological studies t%li%identify and assess environmental risks and ensure compliance with environmental regulations.
Furthermore, increased focus on environmental sustainability and the requirement for regulatory practices t%li%characterize the long-term effects of toxic substances on aquatic ecosystems and pollution-related issues have fueled the market. Likewise, the studies provide crucial insights int%li%pollutant behavior, bioaccumulation, and ecological pathways, helping t%li%prevent environmental disasters and protect human health. Moreover, the companies are significantly focusing on developing formulations and solutions with lesser threats and adverse impacts on environmental entities. Hence, aquatic ecotoxicological studies are crucial t%li%evaluate the safety of these newly developed formulations on aquatic life before their widespread use.
In addition, the market is significantly growing, with players offering various testing services such as acute toxicity tests, chronic toxicity tests, bioaccumulation studies, biodegradation studies, and others, propelling the market growth. In addition, the growing expansion of facilities for aquatic ecotoxicological studies in various regions across the globe is gaining momentum, driven by a growing demand for environmentally friendly and sustainable options. For instance, in October 2022, Charles River Laboratories announced the ecotoxicology expansion of its 16,000 m2 site t%li%meet the growing demand for various time-critical testing programs. In addition, the company has completed the construction of six new ecotoxicology laboratories and has upgraded its existing facilities. At its Den Bosch site, the company will now offer expertise in ecotoxicology, toxicology, and environmental risk assessments. Additionally, new facilities will include a custom-designed fish culture system for aquatic ecotoxicology studies. Besides, in early 2023 the testing volumes performed are expected t%li%increase when changes t%li%endocrine disruptor testing requirements. This expansion will allow the company's clients t%li%effectively continue their studies in accordance with regulatory changes.
Some of the key players in the market are SGS SA, Charles River Laboratories Inc., Laboratory Corporation of America Holdings, Toxi-Coop Ltd., and others. Market players are adopting key strategic initiatives t%li%boost their market presence and expand their business. For instance, in October 2022, EcoAnalysts, Inc. announced its expansion in Florida after its acquisition of Hydrosphere Research Environmental Services, an aquatic ecotoxicity testing service provider.
Aquatic Ecotoxicological Studies Market Report Highlights
- Based on type, the acute toxicity tests segment dominated the market in 2023. The segment growth is driven by the increasing lethal concentrations of a substance in the aquatic ecosystem rising need t%li%meet global regulations across the chemical sector before the products are marketed, including pharmaceuticals, agrochemicals, biocides, and industrial chemicals.
- Based on end use, pharmaceuticals held the largest market share of 39.4% in 2023. The segment growth is driven by significant penetration of aquatic ecotoxicological studies in the pharmaceutical industry t%li%assess the impact of pharmaceutical products and their active pharmaceutical ingredients (APIs) on aquatic organisms and ecosystems.
- Furthermore, in terms of pharmaceuticals, the human medicine sub-segment held the largest market share in 2023. The segment is driven by the growing adoption of sustainable practices and the increasing need t%li%meet environmental safety standards, contributing t%li%its prominence in this field.
- Europe dominated the aquatic ecotoxicological studies market with a share of 32.5% in 2023. The region's growing pollution in European countries has led t%li%an increasing requirement for ecotoxicological studies t%li%assess the toxicity of chemicals and further detect the effects in the ecosystems caused by the pollutants, contributing t%li%market growth.
CHAPTER 1. RESEARCH METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Objectives
1.5.1. Objective-1
1.5.2. Objective-2
1.5.3. Objective-3
1.6. Research Methodology
1.7. Information Procurement
1.7.1. Purchased Database
1.7.2. GVR’s Internal Database
1.7.3. Secondary Sources
1.7.4. Primary Research
1.8. Information Or Data Analysis
1.8.1. Data Analysis Models
1.9. Market Formulation & Validation
1.10. Model Details
1.10.1. Commodity Flow Analysis
1.10.2. Parent Market Analysis
1.11. List Of Secondary Sources
1.12. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Product Pipeline Analysis, by Service
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing popularity of In Silico Toxicology
3.3.1.2. Integration with Environmental Monitoring Tools
3.3.1.3. Increasing Efforts for Adoption
3.3.1.4. Preference towards Customization and Flexibility
3.3.2. Market Restraint Analysis
3.4. Aquatic Ecotoxicological Studies Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat Of New Entrant
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.3. COVID-19 Impact Analysis
3.4.4. Major Deals & Strategic Alliances Analysis
3.4.4.1. Geographic Expansions
3.4.4.2. Mergers & Acquisitions
CHAPTER 4. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Aquatic Ecotoxicological Studies Market, By Type: Segment Dashboard
4.2. Aquatic Ecotoxicological Studies Market, By Type: Movement Analysis
4.3. Aquatic Ecotoxicological Studies Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Acute Toxicity Tests
4.3.1.1. Acute Toxicity Tests Market, 2018 to 2030 (USD Million)
4.3.2. Chronic Toxicity Tests
4.3.2.1. Chronic Toxicity Tests Market, 2018 to 2030 (USD Million)
4.3.3. Bioaccumulation Studies
4.3.3.1. Bioaccumulation studies Market, 2018 to 2030 (USD Million)
4.3.4. Biodegradation Studies
4.3.4.1. Biodegradation Studies Market, 2018 to 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 5. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Aquatic Ecotoxicological Studies Market, By End Use: Segment Dashboard
5.2. Aquatic Ecotoxicological Studies Market, By End Use: Movement Analysis
5.3. Aquatic Ecotoxicological Studies Market Estimates & Forecasts, By End Use, 2018 - 2030
5.3.1. Pharmaceuticals
5.3.1.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)
5.3.1.2. Human Medicine
5.3.1.2.1. Human Medicine Market, 2018 to 2030 (USD Million)
5.3.1.3. Veterinary Medicine
5.3.1.3.1. Veterinary Medicine Market, 2018 to 2030 (USD Million)
5.3.2. Biocides
5.3.2.1. Biocides Market, 2018 to 2030 (USD Million)
5.3.3. Agrochemicals
5.3.3.1. Agrochemicals Market, 2018 to 2030 (USD Million)
5.3.4. Chemicals & Petrochemicals
5.3.4.1. Chemicals & Petrochemicals Market, 2018 to 2030 (USD Million)
5.3.5. Others
5.3.5.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 6. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.5.9. Netherlands
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.5.10. Switzerland
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Argentina
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2023
7.2. Company Profiles
7.2.1. Charles River Laboratories, Inc.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. SGS SA
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Laboratory Corporation of America Holdings
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Smithers
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Aragen Life Sciences Pvt. Ltd.
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Fera Science Limited
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Noack Laboratorien GmbH
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Eurofins Agroscience Services Group
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. ibacon GmbH
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. BRF (Bioscience Research Foundation)
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. Toxi-Coop Ltd.
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Objectives
1.5.1. Objective-1
1.5.2. Objective-2
1.5.3. Objective-3
1.6. Research Methodology
1.7. Information Procurement
1.7.1. Purchased Database
1.7.2. GVR’s Internal Database
1.7.3. Secondary Sources
1.7.4. Primary Research
1.8. Information Or Data Analysis
1.8.1. Data Analysis Models
1.9. Market Formulation & Validation
1.10. Model Details
1.10.1. Commodity Flow Analysis
1.10.2. Parent Market Analysis
1.11. List Of Secondary Sources
1.12. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Product Pipeline Analysis, by Service
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing popularity of In Silico Toxicology
3.3.1.2. Integration with Environmental Monitoring Tools
3.3.1.3. Increasing Efforts for Adoption
3.3.1.4. Preference towards Customization and Flexibility
3.3.2. Market Restraint Analysis
3.4. Aquatic Ecotoxicological Studies Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat Of New Entrant
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.3. COVID-19 Impact Analysis
3.4.4. Major Deals & Strategic Alliances Analysis
3.4.4.1. Geographic Expansions
3.4.4.2. Mergers & Acquisitions
CHAPTER 4. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Aquatic Ecotoxicological Studies Market, By Type: Segment Dashboard
4.2. Aquatic Ecotoxicological Studies Market, By Type: Movement Analysis
4.3. Aquatic Ecotoxicological Studies Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Acute Toxicity Tests
4.3.1.1. Acute Toxicity Tests Market, 2018 to 2030 (USD Million)
4.3.2. Chronic Toxicity Tests
4.3.2.1. Chronic Toxicity Tests Market, 2018 to 2030 (USD Million)
4.3.3. Bioaccumulation Studies
4.3.3.1. Bioaccumulation studies Market, 2018 to 2030 (USD Million)
4.3.4. Biodegradation Studies
4.3.4.1. Biodegradation Studies Market, 2018 to 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 5. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Aquatic Ecotoxicological Studies Market, By End Use: Segment Dashboard
5.2. Aquatic Ecotoxicological Studies Market, By End Use: Movement Analysis
5.3. Aquatic Ecotoxicological Studies Market Estimates & Forecasts, By End Use, 2018 - 2030
5.3.1. Pharmaceuticals
5.3.1.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)
5.3.1.2. Human Medicine
5.3.1.2.1. Human Medicine Market, 2018 to 2030 (USD Million)
5.3.1.3. Veterinary Medicine
5.3.1.3.1. Veterinary Medicine Market, 2018 to 2030 (USD Million)
5.3.2. Biocides
5.3.2.1. Biocides Market, 2018 to 2030 (USD Million)
5.3.3. Agrochemicals
5.3.3.1. Agrochemicals Market, 2018 to 2030 (USD Million)
5.3.4. Chemicals & Petrochemicals
5.3.4.1. Chemicals & Petrochemicals Market, 2018 to 2030 (USD Million)
5.3.5. Others
5.3.5.1. Others Market, 2018 to 2030 (USD Million)
CHAPTER 6. AQUATIC ECOTOXICOLOGICAL STUDIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.5.9. Netherlands
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.5.10. Switzerland
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Argentina
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2023
7.2. Company Profiles
7.2.1. Charles River Laboratories, Inc.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. SGS SA
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Laboratory Corporation of America Holdings
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Smithers
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Aragen Life Sciences Pvt. Ltd.
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Fera Science Limited
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Noack Laboratorien GmbH
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Eurofins Agroscience Services Group
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. ibacon GmbH
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. BRF (Bioscience Research Foundation)
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. Toxi-Coop Ltd.
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
LIST OF TABLES
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. North America aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 4. North America aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 5. North America aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 6. U.S. aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 7. U.S. aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 8. Canada aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 9. Canada aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 10. Mexico aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 11. Mexico aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 12. Europe aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 13. Europe aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 14. Europe aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 15. UK aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 16. UK aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 17. Germany aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 18. Germany aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 19. France aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 20. France aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 21. Italy aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 22. Italy aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 23. Spain aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 24. Spain aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 25. Denmark aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 26. Denmark aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 27. Sweden aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 28. Sweden aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 29. Norway aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 30. Norway aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 31. Netherlands aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 32. Netherlands aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 33. Switzerland aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 34. Switzerland aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 35. Asia Pacific aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 36. Asia Pacific aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 37. Asia Pacific aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 38. Japan aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 39. Japan aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 40. China aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 41. China aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 42. India aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 43. India aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 44. Australia aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 45. Australia aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 46. South Korea aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 47. South Korea aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 48. Thailand aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 49. Thailand aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 50. Latin America aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 51. Latin America aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 52. Latin America aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 53. Brazil aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 54. Brazil aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 55. Argentina aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 56. Argentina aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 59. Middle East & Africa aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. North America aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 4. North America aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 5. North America aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 6. U.S. aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 7. U.S. aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 8. Canada aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 9. Canada aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 10. Mexico aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 11. Mexico aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 12. Europe aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 13. Europe aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 14. Europe aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 15. UK aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 16. UK aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 17. Germany aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 18. Germany aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 19. France aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 20. France aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 21. Italy aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 22. Italy aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 23. Spain aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 24. Spain aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 25. Denmark aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 26. Denmark aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 27. Sweden aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 28. Sweden aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 29. Norway aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 30. Norway aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 31. Netherlands aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 32. Netherlands aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 33. Switzerland aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 34. Switzerland aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 35. Asia Pacific aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 36. Asia Pacific aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 37. Asia Pacific aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 38. Japan aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 39. Japan aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 40. China aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 41. China aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 42. India aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 43. India aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 44. Australia aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 45. Australia aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 46. South Korea aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 47. South Korea aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 48. Thailand aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 49. Thailand aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 50. Latin America aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 51. Latin America aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 52. Latin America aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 53. Brazil aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 54. Brazil aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 55. Argentina aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 56. Argentina aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa aquatic ecotoxicological studies market, by region, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa aquatic ecotoxicological studies market, by type, 2018 - 2030 (USD Million)
Table 59. Middle East & Africa aquatic ecotoxicological studies market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Rheumatoid arthritis therapeutics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Molecule and sales channel segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global Pharmaceutical Market, (USD billion)
Fig. 13 Market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Rheumatoid arthritis therapeutics: Molecule outlook and key takeaways
Fig. 17 Rheumatoid arthritis therapeutics market: Molecule market movement analysis
Fig. 18 Biopharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 TNF-? antagonists market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 T-cell inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 CD20 antigen market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Anti-IL6 biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 CD20 antigen market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 TNF-? antagonists market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Analgesics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 DMARDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Glucocorticoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Rheumatoid arthritis therapeutics: Sales channel outlook and key takeaways
Fig. 34 Rheumatoid arthritis therapeutics market: Sales channel market movement analysis
Fig. 35 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Over-the-Counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Rheumatoid arthritis therapeutics market revenue, by region, 2023 & 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 U.S. rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 U.S. healthcare system: money flow
Fig. 44 Key country dynamics
Fig. 45 Canada rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Drug pricing
Fig. 47 Key country dynamics
Fig. 48 Mexico rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Regulatory framework
Fig. 50 Europe rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 UK rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Germany rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 France rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Italy rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Denmark rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Sweden rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Norway rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Rest of Europe rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Japan rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 China rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 China regulatory details
Fig. 74 India rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Australia rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Thailand rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Korea rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 South Korea reimbursement scenario
Fig. 82 Rest of Asia Pacific rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Brazil regulation details
Fig. 87 Brazil reimbursement scenario
Fig. 88 Key country dynamics
Fig. 89 Argentina rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Argentina regulatory framework
Fig. 91 Rest of Latin America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Africa rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Saudi Arabia rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 UAE rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Kuwait rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2023 (USD Million)
Fig. 100 Rest of MEA rheumatoid arthritis therapeutics market estimates and forecasts,
Fig. 101 Company/competition categorization
Fig. 102 Company market share analysis, 2023
Fig. 103 Strategy mapping
Fig. 1 Rheumatoid arthritis therapeutics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Molecule and sales channel segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global Pharmaceutical Market, (USD billion)
Fig. 13 Market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Rheumatoid arthritis therapeutics: Molecule outlook and key takeaways
Fig. 17 Rheumatoid arthritis therapeutics market: Molecule market movement analysis
Fig. 18 Biopharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 TNF-? antagonists market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 T-cell inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 CD20 antigen market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Anti-IL6 biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 CD20 antigen market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 TNF-? antagonists market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Analgesics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 DMARDs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Glucocorticoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Rheumatoid arthritis therapeutics: Sales channel outlook and key takeaways
Fig. 34 Rheumatoid arthritis therapeutics market: Sales channel market movement analysis
Fig. 35 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Over-the-Counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Rheumatoid arthritis therapeutics market revenue, by region, 2023 & 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 U.S. rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 U.S. healthcare system: money flow
Fig. 44 Key country dynamics
Fig. 45 Canada rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Drug pricing
Fig. 47 Key country dynamics
Fig. 48 Mexico rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Regulatory framework
Fig. 50 Europe rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 UK rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Germany rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 France rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Italy rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Denmark rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Sweden rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Norway rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Rest of Europe rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Japan rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 China rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 China regulatory details
Fig. 74 India rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Australia rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Thailand rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Korea rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 South Korea reimbursement scenario
Fig. 82 Rest of Asia Pacific rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Brazil regulation details
Fig. 87 Brazil reimbursement scenario
Fig. 88 Key country dynamics
Fig. 89 Argentina rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Argentina regulatory framework
Fig. 91 Rest of Latin America rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Africa rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Saudi Arabia rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 UAE rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Kuwait rheumatoid arthritis therapeutics market estimates and forecasts, 2018 - 2023 (USD Million)
Fig. 100 Rest of MEA rheumatoid arthritis therapeutics market estimates and forecasts,
Fig. 101 Company/competition categorization
Fig. 102 Company market share analysis, 2023
Fig. 103 Strategy mapping
